Literature DB >> 32841326

Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis.

Anita Morandi1, Anna Di Sessa2, Chiara Zusi1, Giuseppina Rosaria Umano2, Dania El Mazloum1, Elena Fornari1, Emanuele Miraglia Del Giudice2, Giovanni Targher3, Claudio Maffeis1.   

Abstract

CONTEXT: Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR) and predicts type 2 diabetes. Currently, it is uncertain whether NAFLD may directly cause IR or vice versa.
OBJECTIVE: To test the hypothesis that NAFLD is causally related to IR. DESIGN AND METHODS: We performed a Mendelian randomization (MR) in 904 obese children/adolescents using an NAFLD-related genetic risk score (GRS) as an instrumental variable. We assessed NAFLD by ultrasonography and IR by homeostasis model assessment (HOMA-IR). We also interrogated the MAGIC Consortium dataset of 46 186 adults to assess the association between PNPLA3 rs738409 (ie, the most robust NAFLD-related polymorphism) and HOMA-IR, and we performed a 2-sample MR with 2 large datasets to test reverse causation (HOMA-IR increasing the risk of NAFLD).
RESULTS: Nonalcoholic fatty liver disease prevalence increased by 20% for every increase in the GRS (β-coefficient = 0.20, P < 0.001), and NAFLD was associated with ln-HOMA-IR (β-coefficient = 0.28, P < 0.001). Thus, the expected increase in ln-HOMA-IR for every increase in the GRS (expected β-coefficient) was 0.056 (0.28*0.20) in the case of complete NAFLD-HOMA-IR causal association, and 0.042 in the case of 75% causality. In our cohort, the GRS did not predict ln-HOMA-IR (β-coefficient = 0.007, P = 0.75). In the MAGIC cohort, the PNPLA3 rs738409 did not associate with ln-HOMA-IR. The 2-sample MR failed to show a causal association between ln-HOMA-IR and NAFLD.
CONCLUSIONS: Our study shows that genetically-influenced NAFLD does not increase HOMA-IR, and genetically-influenced HOMA-IR does not increase the risk of NAFLD. Shared pathogenic pathways or NAFLD subtypes not "captured" by our MR design might underpin the association between NAFLD and HOMA-IR. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NAFLD; causal association; childhood obesity; insulin resistance

Year:  2020        PMID: 32841326     DOI: 10.1210/clinem/dgaa583

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics.

Authors:  Simona Riccio; Rosa Melone; Caterina Vitulano; Pierfrancesco Guida; Ivan Maddaluno; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Pediatr       Date:  2022-03-23

Review 2.  Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.

Authors:  Serena Scapaticci; Ebe D'Adamo; Angelika Mohn; Francesco Chiarelli; Cosimo Giannini
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-06       Impact factor: 5.555

3.  Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Yong-Tian Zheng; Tian-Mei Xiao; Chan-Xian Wu; Jin-Yan Cheng; Le-Yu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 5.555

4.  Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity.

Authors:  Marco Carotenuto; Anna Di Sessa; Maria Esposito; Anna Grandone; Pierluigi Marzuillo; Ilaria Bitetti; Giuseppina Rosaria Umano; Francesco Precenzano; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  Children (Basel)       Date:  2021-11-01

5.  Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.

Authors:  Lucas Opazo-Ríos; Manuel Soto-Catalán; Iolanda Lázaro; Aleix Sala-Vila; Luna Jiménez-Castilla; Macarena Orejudo; Juan Antonio Moreno; Jesús Egido; Sebastián Mas-Fontao
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 6.  COVID-19 and pediatric fatty liver disease: Is there interplay?

Authors:  Anna Di Sessa; Francesca Lanzaro; Sarah Zarrilli; Vittorio Picone; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

Review 7.  Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics.

Authors:  Anna Di Sessa; Simona Riccio; Emilia Pirozzi; Martina Verde; Antonio Paride Passaro; Giuseppina Rosaria Umano; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

8.  MAFLD in Obese Children: A Challenging Definition.

Authors:  Anna Di Sessa; Stefano Guarino; Giuseppina Rosaria Umano; Mattia Arenella; Salvatore Alfiero; Gaetano Quaranta; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  Children (Basel)       Date:  2021-03-23

Review 9.  Omics era in type 2 diabetes: From childhood to adulthood.

Authors:  Antonio Paride Passaro; Pierluigi Marzuillo; Stefano Guarino; Federica Scaglione; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Diabetes       Date:  2021-12-15

10.  Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

Authors:  Daniel J Cuthbertson; Juha Koskinen; Emily Brown; Costan G Magnussen; Nina Hutri-Kähönen; Matthew Sabin; Päivi Tossavainen; Eero Jokinen; Tomi Laitinen; Jorma Viikari; Olli T Raitakari; Markus Juonala
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.